Skip to Main Content

Advertisement

Skip Nav Destination

In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

J Immunol (1988) 140 (12): 4342–4347.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal